BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2455988)

  • 1. The effect of serine esterase inhibitors on ionophore-induced histamine release from human pulmonary mast cells.
    Hultsch T; Ennis M; Heidtmann HH
    Agents Actions; 1988 Apr; 23(3-4):198-200. PubMed ID: 2455988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors.
    He S; Xie H
    Asian Pac J Allergy Immunol; 2004 Dec; 22(4):205-12. PubMed ID: 15783133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of tryptase release from human tonsil mast cells by protease inhibitors.
    He S; Xie H
    Pharmacol Rep; 2005; 57(4):523-30. PubMed ID: 16129920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chymase in ionophore-induced histamine release from human pulmonary mast cells.
    Hultsch T; Ennis M; Heidtmann HH
    Adv Exp Med Biol; 1988; 240():133-6. PubMed ID: 2469301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a chymotrypsin-like inhibitor, TPCK, on histamine release from cultured human mast cells.
    Yanagida M; Fukamachi H; Takei M; Uzumaki H; Saito TT; Iikura Y; Nakahata T
    J Pharm Pharmacol; 1997 May; 49(5):537-41. PubMed ID: 9178191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of histamine release from human colon mast cells by protease inhibitors.
    He SH; Xie H
    World J Gastroenterol; 2004 Feb; 10(3):337-41. PubMed ID: 14760753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
    Frydrych I; Mlejnek P
    J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
    He S; Gaça MD; Walls AF
    Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tryptase release from human colon mast cells by protease inhibitors.
    He SH; Xie H
    World J Gastroenterol; 2004 Feb; 10(3):332-6. PubMed ID: 14760752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound 48/80-induced secretion of histamine from rat peritoneal mast cells depends on a tryptase controlled step also leading to chymase activity.
    Vassimon CS; Rothschild AM
    Agents Actions; 1990 Apr; 30(1-2):150-2. PubMed ID: 1695438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of tryptase inhibitors on histamine release from human colon mast cells].
    Xie H; He SH; Cheng MH; Fu YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):678-81. PubMed ID: 15555433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates.
    Dallegri F; Frumento G; Ballestrero A; Goretti R; Torresin A; Patrone F
    Immunology; 1987 Nov; 62(3):387-91. PubMed ID: 3666787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) do not inhibit caspase-3 and caspase-7 processing in cells exposed to pro-apoptotic inducing stimuli.
    Frydrych I; Mlejnek P
    J Cell Biochem; 2008 Dec; 105(6):1501-6. PubMed ID: 18980241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histamine release from human mast cells by natural chymase inhibitors.
    He SH; Xie H; Zhang XJ; Wang XJ
    Acta Pharmacol Sin; 2004 Jun; 25(6):822-6. PubMed ID: 15169639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase inhibitors TPCK and TLCK prevent Entamoeba histolytica induced disturbance of tight junctions and microvilli in enteric cell layers in vitro.
    Lauwaet T; Oliveira MJ; Callewaert B; De Bruyne G; Mareel M; Leroy A
    Int J Parasitol; 2004 Jun; 34(7):785-94. PubMed ID: 15157761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotactic factor-induced superoxide radical generation by human neutrophils: requirement for proteinase (esterase) activity.
    Simchowitz L; Mehta J; Spilberg I
    J Lab Clin Med; 1979 Sep; 94(3):403-13. PubMed ID: 224122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B.
    Kim H; Lee HS; Chang KT; Ko TH; Baek KJ; Kwon NS
    J Immunol; 1995 May; 154(9):4741-8. PubMed ID: 7536778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-alpha-Tosyl-L-lysine chloromethyl ketone and N-alpha-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C.
    Solomon DH; O'Brian CA; Weinstein IB
    FEBS Lett; 1985 Oct; 190(2):342-4. PubMed ID: 4043411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chymotryptic-type protease inhibitor decreases interleukin 2 synthesis and induces prostaglandin production in Jurkat T cells.
    Auberger P; Didier M; Didier J; Aussel C; Fehlmann M
    Cell Signal; 1989; 1(3):289-94. PubMed ID: 2641884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine protease inhibitors interact with IFN-γ through up-regulation of FasR; a novel therapeutic strategy against cancer.
    Shadrin N; Shapira MG; Khalfin B; Uppalapati L; Parola AH; Nathan I
    Exp Cell Res; 2015 Jan; 330(2):233-239. PubMed ID: 25449698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.